logo

Moleculin Biotech Inc (MBRX)



Trade MBRX now with
  Date
  Headline
12/29/2020 7:32:38 AM Moleculin Says Annamycin Receives FDA Orphan Drug Designation For Soft Tissue Sarcomas; Stock Surges
12/17/2020 7:43:10 AM Moleculin: FDA Allowing IND Application To Study Annamycin For Soft Tissue Sarcoma Lung Metastases To Go Into Effect
12/1/2020 7:37:23 AM Moleculin Biotech Says FDA Approved Its Request For A "Rare Pediatric Disease" Designation For WP1066
11/19/2020 7:36:50 AM Moleculin Says New Data Shows Synergistic Antitumor Activity Of Annamycin Combination With Ara-C In AML
11/13/2020 7:34:18 AM Moleculin Biotech Q3 Loss Per Share $0.06 Vs Loss $0.09 Last Year
10/29/2020 7:45:34 AM Moleculin Unveils Addl. Collaboration On Drug Candidate Targeting COVID-19
10/13/2020 7:32:19 AM Moleculin Announces Additional Positive Interim Results In Adult Glioblastoma Clinical Trial
10/6/2020 7:35:30 AM Moleculin Biotech Announces New Findings In Vitro Activity Against HIV
10/5/2020 7:36:01 AM Moleculin Biotech Appoints Elizabeth Cermak To Board
10/1/2020 7:41:44 AM Moleculin Announces Positive Interim Results In Pediatric Brain Tumor Phase 1 Trial At Emory University
9/29/2020 7:59:41 AM Moleculin Announces Discovery Of Significant In Vitro Activity Against COVID-19 Virus For New Antimetabolites
9/14/2020 7:39:19 AM Moleculin Biotech To Test Antiviral Activity Of WP1122 In COVID-19 Animal Model